Influence of culture time on the expression of drug-metabolizing enzymes in primary human hepatocytes and hepatoma cell line HepG2

被引:70
作者
Wilkening, S
Bader, A
机构
[1] German Res Ctr Biotechnol, D-38124 Braunschweig, Germany
[2] Biomed Biotechnol Ctr, D-04103 Leipzig, Germany
关键词
quantitative real-time RT-PCR; gene expression; LightCycler; cytochrome P450; phase II enzymes; days in culture; passages; human liver;
D O I
10.1002/jbt.10085
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Primary cultures of human hepatocytes and hepatoma cell line HepG2 are frequently used to evaluate the hepatic disposition of drugs and other xenobiotics. To check the variability of the expression of drug-metabolizing enzymes in these in vitro models, expression of genes coding for several cytochrome P450 isoforms and phase 11 enzymes was quantified during culture time by real-time RT-PCR. Gene expression was determined daily for primary hepatocytes maintained in a sandwich culture over 1 week and for HepG2, during the first 10 passages. In primary hepatocytes characteristic expression trends were observed which could be abstracted into three major classes of time curves. Genes of the first and the second class had an expression maximum around day 6 and day 4 in culture, respectively. The third class of genes had two expression peaks: at day 1 and 5 in culture. Surprisingly, also the cell line HepG2 showed significant expression changes during passages. For example, gene expression of cytochrome 1A1 varied 8-fold, that of cytochrome 2136 30-fold, and that of NADP-quinone reductase 1 more than 200-fold within the first 10 passages. In conclusion, neither primary hepatocytes nor HepG2 cell line display a model for constant expression of drug-metabolizing enzymes. (C) 2003 Wiley Periodicals, Inc.
引用
收藏
页码:207 / 213
页数:7
相关论文
共 27 条
[1]   CONTROLLED SYNTHESIS OF HBSAG IN A DIFFERENTIATED HUMAN-LIVER CARCINOMA-DERIVED CELL-LINE [J].
ADEN, DP ;
FOGEL, A ;
PLOTKIN, S ;
DAMJANOV, I ;
KNOWLES, BB .
NATURE, 1979, 282 (5739) :615-616
[2]   Quantification of multiple human cytochrome P450 mRNA molecules using competitive reverse transcriptase-PCR [J].
Andersen, MR ;
Farin, FM ;
Omiecinski, CJ .
DNA AND CELL BIOLOGY, 1998, 17 (03) :231-238
[3]   USE OF ORGANOTYPICAL CULTURES OF PRIMARY HEPATOCYTES TO ANALYZE DRUG BIOTRANSFORMATION IN MAN AND ANIMALS [J].
BADER, A ;
ZECH, K ;
CROME, O ;
CHRISTIANS, U ;
RINGE, B ;
PICHLMAYR, R ;
SEWING, KF .
XENOBIOTICA, 1994, 24 (07) :623-633
[4]   OXIDATION OF BENZO[A]PYRENE BY RECOMBINANT HUMAN CYTOCHROME-P450 ENZYMES [J].
BAUER, E ;
GUO, ZY ;
UENG, YF ;
BELL, LC ;
ZELDIN, D ;
GUENGERICH, FP .
CHEMICAL RESEARCH IN TOXICOLOGY, 1995, 8 (01) :136-142
[5]  
Bowen WP, 2000, DRUG METAB DISPOS, V28, P781
[6]   The pitfall of detoxifying enzymes [J].
Cantelli-Forti, G ;
Hrelia, P ;
Paolini, M .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1998, 402 (1-2) :179-183
[7]   VARIATION IN DRUG-METABOLIZING ENZYME-ACTIVITIES DURING THE GROWTH OF HUMAN HEP G2 HEPATOMA-CELLS [J].
DOOSTDAR, H ;
DEMOZ, A ;
BURKE, MD ;
MELVIN, WT ;
GRANT, MH .
XENOBIOTICA, 1990, 20 (04) :435-441
[8]   HEPATOCYTE FUNCTION AND EXTRACELLULAR-MATRIX GEOMETRY - LONG-TERM CULTURE IN A SANDWICH CONFIGURATION [J].
DUNN, JCY ;
YARMUSH, ML ;
KOEBE, HG ;
TOMPKINS, RG .
FASEB JOURNAL, 1989, 3 (02) :174-177
[9]   COLLAGEN SUBSTRATA FOR STUDIES ON CELL BEHAVIOR [J].
ELSDALE, T ;
BARD, J .
JOURNAL OF CELL BIOLOGY, 1972, 54 (03) :626-&
[10]   Contribution of human cytochrome P450 to benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol metabolism, as predicted from heterologous expression in yeast [J].
Gautier, JC ;
Lecoeur, S ;
Cosme, J ;
Perret, A ;
Urban, P ;
Beaune, P ;
Pompon, D .
PHARMACOGENETICS, 1996, 6 (06) :489-499